Back to calendar
Kairos Pharma, Ltd. (KAPA) Earnings
KAPA reports earnings on Wednesday, December 2, 2026
earnings report
December 2, 2026 · Before Market Open
Q3 2026
Est. EPS: $-0.63
Actual EPS: $-0.63
EPS surprise: -12.50%
Company overview
Market Cap$1.7M
PriceUSD 0.49
EPS (TTM)-1.95
52-week high7.28
52-week low0.42
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees4